In this study, we used mediation analysis to quantify the contributions of ODX testing and stage at diagnosis to the association between SES and OS in women with HR+/HER2- breast cancer, and to the best of our knowledge this is the first such study. This evidence concerns the gene ERBB2 and breast cancer.